Departments of Pediatrics (Division of Pediatric Respiratory Medicine), University of California-San Diego School of Medicine, San Diego, CA, USA.
J Clin Sleep Med. 2012 Jun 15;8(3):271-7. doi: 10.5664/jcsm.1912.
The ApneaLink Plus is a portable recording device that measures air flow, respiratory effort, heart rate, and pulse oximetry. In the current study, we asked whether this device could be used to screen for obstructive sleep apnea in the pediatric population.
Sleep-laboratory polysomnography (PSG) was performed simultaneously with measurements using the portable device on obese pediatric patients referred for snoring. The obstructive apnea hypopnea index (OAHI) was calculated automatically by the device (autoscore) and manually by the investigators. Sensitivity, specificity, correlation, and receiver operating curves (ROC) were used to compare the portable device to PSG.
Twenty-five subjects (60% male, mean age 13.6 ± 3.0 years, OAHI on PSG 11.8 ± 27.1) were studied. We identified a significant correlation between the OAHI of the ApneaLink autoscore and PSG (Spearman Rho = 0.886 [p < 0.001]). Using the PSG results as standard, ROC curves comparing the ApneaLink OAHI with the PSG OAHI demonstrated high congruence. The autoscore agreement was very good at PSG OAHI > 1.5 (area under the receiver operating curve [AUC] 0.965, OAHI > 5 [AUC 0.937], and OAHI > 10 [AUC 1.00]). The agreement of the manual score and autoscore were essentially equivalent. The device's autoscore demonstrated high sensitivity at all cutoffs examined (100% at OAHI > 1.5, 85.7% at OAHI > 5, and 100% at OAHI > 10). The specificity increased with increasing cutoffs (46.2% at OAHI > 1.5, 83.3% at OAHI > 5, and 90.0% at OAHI > 10).
he ApneaLink Plus is a sensitive screening tool for evaluation of suspected OSAS in obese pediatric patients aged 9-18 years. The specificity improves with increasing OAHI cutoffs. The device detects OSAS when tested in a sleep laboratory on obese adolescents referred for symptoms of sleep related breathing disorder.
ApneaLink Plus 是一种便携式记录设备,可测量气流、呼吸努力、心率和脉搏血氧饱和度。在本研究中,我们询问该设备是否可用于筛查儿科人群中的阻塞性睡眠呼吸暂停。
对因打鼾而接受睡眠实验室多导睡眠图(PSG)检查的肥胖儿科患者同时使用便携式设备进行测量。设备自动(自动评分)和研究人员手动计算阻塞性呼吸暂停低通气指数(OAHI)。使用灵敏度、特异性、相关性和接收者操作特征曲线(ROC)将便携式设备与 PSG 进行比较。
共研究了 25 名受试者(60%为男性,平均年龄 13.6 ± 3.0 岁,PSG 上的 OAHI 为 11.8 ± 27.1)。我们发现 ApneaLink 自动评分的 OAHI 与 PSG 之间存在显著相关性(Spearman Rho = 0.886 [p < 0.001])。使用 PSG 结果作为标准,比较 ApneaLink OAHI 与 PSG OAHI 的 ROC 曲线表明高度一致。在 PSG OAHI > 1.5 时(接受者操作曲线下面积 [AUC] 0.965,OAHI > 5 [AUC 0.937]和 OAHI > 10 [AUC 1.00]),自动评分的协议非常好。手动评分和自动评分的协议基本相同。该设备的自动评分在所有检查的截止值处均具有高灵敏度(OAHI > 1.5 时为 100%,OAHI > 5 时为 85.7%,OAHI > 10 时为 100%)。特异性随截止值的增加而增加(OAHI > 1.5 时为 46.2%,OAHI > 5 时为 83.3%,OAHI > 10 时为 90.0%)。
ApneaLink Plus 是一种用于评估 9-18 岁肥胖儿科患者疑似 OSAS 的敏感筛查工具。特异性随 OAHI 截止值的增加而提高。当在睡眠实验室中对因睡眠相关呼吸障碍症状而接受检查的肥胖青少年进行测试时,该设备可检测到 OSAS。